Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clément Prati

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Nature Reviews. Rheumatology|February 24, 2017
Spondyloarthropathies: Fine tuning the management of axial spondyloarthritisDaniel Wendling, Clément Prati
Expert Review of Clinical Immunology|June 5, 2013
Spondyloarthritis and smoking: towards a new insight into the diseaseDaniel Wendling, Clément Prati
The Journal of Rheumatology|September 3, 2017
Spondyloarthritis: Harlequin or Chameleon?Daniel Wendling, Clément Prati
Clinical Rheumatology|July 23, 2016
Spondyloarthritis and fibromyalgia: interfering association or differential diagnosis?Daniel Wendling, Clément Prati
Annals of the Rheumatic Diseases|March 17, 2016
Flare in axial spondyloarthritis. The dark side of the outcomeDaniel Wendling, Clément Prati
Joint Bone Spine|May 13, 2017
Spondyloarthritis: An expanding cast of cellular actorsDaniel Wendling, Clément Prati
Joint Bone Spine|August 2, 2011
Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonistsDaniel Wendling, Clément Prati
La Revue Du Praticien|February 1, 2012
[Pain and joint effusion. Recent arthritis. Working diagnosis]Clément Prati, Daniel Wendling
Expert Review of Clinical Immunology|December 12, 2013
Paradoxical effects of anti-TNF-α agents in inflammatory diseasesDaniel Wendling, Clément Prati
Joint Bone Spine|December 3, 2010
Using targeted therapies alone for rheumatoid arthritisClément Prati, Daniel Wendling
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Nature Reviews. Rheumatology|February 24, 2017
Spondyloarthropathies: Fine tuning the management of axial spondyloarthritisDaniel Wendling, Clément Prati
Expert Review of Clinical Immunology|June 5, 2013
Spondyloarthritis and smoking: towards a new insight into the diseaseDaniel Wendling, Clément Prati
The Journal of Rheumatology|September 3, 2017
Spondyloarthritis: Harlequin or Chameleon?Daniel Wendling, Clément Prati
Clinical Rheumatology|July 23, 2016
Spondyloarthritis and fibromyalgia: interfering association or differential diagnosis?Daniel Wendling, Clément Prati
Annals of the Rheumatic Diseases|March 17, 2016
Flare in axial spondyloarthritis. The dark side of the outcomeDaniel Wendling, Clément Prati
Joint Bone Spine|May 13, 2017
Spondyloarthritis: An expanding cast of cellular actorsDaniel Wendling, Clément Prati
Joint Bone Spine|August 2, 2011
Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonistsDaniel Wendling, Clément Prati
La Revue Du Praticien|February 1, 2012
[Pain and joint effusion. Recent arthritis. Working diagnosis]Clément Prati, Daniel Wendling
Expert Review of Clinical Immunology|December 12, 2013
Paradoxical effects of anti-TNF-α agents in inflammatory diseasesDaniel Wendling, Clément Prati
Joint Bone Spine|December 3, 2010
Using targeted therapies alone for rheumatoid arthritisClément Prati, Daniel Wendling
Pageof 24